Liver Disease

As many as 3 in 5 people with type 2 diabetes have a build-up of fat in their liver.

Learn about a new clinical research study.
A clinical research study brings people together to gather information to advance science and medicine.
To learn more about this clinical research study, please contact us:
National Research Institute
1-877-720-7474

Is Fatty Liver Disease Hanging Over Your Head?

Along with investigating a potential new treatment option for nonalcoholic steatohepatitis (NASH), a form of severe fatty liver disease, the SYNERGY-NASH Study is also providing resources like lifestyle and weight management counseling.

Are you suffering from a Fatty Liver?

See if you are eligible to participate in a study evaluating an investigational drug for the treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH). To qualify you must:

  • be between the ages of 18 and 75
  • Have had a liver biopsy or be willing to undergo a liver biopsy

Qualified participants may receive:

  • Compensation for time and travel
  • Study-related care at no cost
  • Ask us about your liver.
    National Research Institute
    877.719.6767
    14418 Chase Street #200
    Panorama CIty, CA 91402

    NASH

    NASH is an advanced form of fatty liver disease called non-alcoholic steato-hepatitis.

    If you have NASH you may be able to participate in this research study. If you qualify, your participation will last up to 6 years with up to 8 office visits in the first year and a half and 2 office visits every year following.

    Study drug, study-related and all study tests will be provided at no charge. Eligible participants may also be reimbursed for travel expenses.

    Our Response to COVID-19
    X